Accueil
Amy Rider
Amy Rider
Publications (9)
A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe.
Journal of bone oncology
Avec:
Jean-Jacques Body
,
Roger von Moos
,
Alex Rider
,
Pamela Hallworth
,
Debajyoti Bhowmik
,
Francesca Gatta
,
Guy Hechmati
,
Yi Qian
Mindful Moms: Motivation to Self-Manage Depression Symptoms.
MCN. The American journal of maternal child nursing
Avec:
Sasha Russell
,
Christine Aubry
,
Amy Rider
,
Suzanne E Mazzeo
,
Patricia A Kinser
Mastery learning improves simulated central venous catheter insertion by emergency medicine teaching faculty.
AEM education and training
Avec:
Nicholas Pokrajac
,
Kimberly Schertzer
,
Kelly N Roszczynialski
,
Ashley Rider
,
Sarah R Williams
,
Cori M Poffenberger
,
Michael A Gisondi
Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Avec:
Pip Griffiths
,
John Devin Peipert
,
Andrea Leith
,
Alex Rider
,
Lucy Morgan
,
David Cella
,
Kim Cocks
Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in Europe.
Bone
Avec:
Roger von Moos
,
Katie Lewis
,
Lucy Massey
,
Andrea Marongiu
,
Alex Rider
,
Anouchka Seesaghur
Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel.
Advances in therapy
Avec:
Reshma Mahtani
,
Alexander Niyazov
,
Katie Lewis
,
Alex Rider
,
Lucy Massey
,
Bhakti Arondekar
,
Michael P Lux
Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel.
Breast (Edinburgh, Scotland)
Avec:
Reshma Mahtani
,
Alexander Niyazov
,
Bhakti Arondekar
,
Katie Lewis
,
Alex Rider
,
Lucy Massey
,
Michael Patrick Lux
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown,
Breast care (Basel, Switzerland)
Avec:
Michael Patrick Lux
,
Katie Lewis
,
Alex Rider
,
Alexander Niyazov
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and Israel.
BMC cancer
Avec:
Reshma Mahtani
,
Alexander Niyazov
,
Bhakti Arondekar
,
Katie Lewis
,
Alex Rider
,
Lucy Massey
,
Michael Patrick Lux
Réseau de co-auteurs
Alex Rider
7 collaborations
Katie Lewis
5 collaborations
Lucy Massey
4 collaborations
Alexander Niyazov
4 collaborations
Reshma Mahtani
3 collaborations
Bhakti Arondekar
3 collaborations
Michael Patrick Lux
3 collaborations
Roger von Moos
2 collaborations
Jean-Jacques Body
1 collaboration
Pamela Hallworth
1 collaboration
Debajyoti Bhowmik
1 collaboration
Francesca Gatta
1 collaboration
Guy Hechmati
1 collaboration
Yi Qian
1 collaboration
Sasha Russell
1 collaboration
Christine Aubry
1 collaboration
Suzanne E Mazzeo
1 collaboration
Patricia A Kinser
1 collaboration
Nicholas Pokrajac
1 collaboration
Kimberly Schertzer
1 collaboration
Kelly N Roszczynialski
1 collaboration
Ashley Rider
1 collaboration
Sarah R Williams
1 collaboration
Cori M Poffenberger
1 collaboration
Michael A Gisondi
1 collaboration
Pip Griffiths
1 collaboration
John Devin Peipert
1 collaboration
Andrea Leith
1 collaboration
Lucy Morgan
1 collaboration
David Cella
1 collaboration
Kim Cocks
1 collaboration
Andrea Marongiu
1 collaboration
Anouchka Seesaghur
1 collaboration
Michael P Lux
1 collaboration